搜索结果
疾病ID:TCMBANKDI010346
疾病名:Esophagitis
MeSH_Name:Digestive System Diseases
HPO_Name:Abnormality of the digestive system; Abnormality of the immune system
UMLS_Name:Disease or Syndrome
DO_Name:disease of anatomical entity
疾病类型:disease
DisGeNET_Link:C0014868
MeSH_Link:C06
HPO_Link:HP:0025031; HP:0002715
UMLS_Link:T047
DO_Link:DOID:7
HERB_ID:-
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN058519 | (-)-epigallocatechin-3-gallate; (-)-epigallocatechin 3-o-gallate;epigallocatechin gallate; galloyl-l-epigallocatechol; epigallocatechin 3-gallate; (-)-epigallocatechin gallate; | KBio2_000796; SpecPlus_000277; 50299_FLUKA; Spectrum3_000244; KBioGR_002002; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] ester; MLS000758300; DivK1c_006373; (−)-Epigallocatechin gallate; EGCG; SPBio_000035; (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; KBioSS_000796; Epigallocatechin gallate; Spectrum4_001541; (-)-epigallocatechin 3-gallate; Tea catechin; AIDS000674; KBio2_005932; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-chromanyl] ester; KBio1_001317; 989-51-5; AIDS-000674; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); KBio2_003364; Galloyl-L-epigallocatechol; SDCCGMLS-0066550.P001; (-)-Epigallocatechol gallate; ACon1_001054; Spectrum5_000102; Green tea extract; MEGxp0_001166; C09731; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; (-)-Epigallocatechin gallate; CCRIS 3729; Teavigo; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Spectrum2_000168; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxy-flavane-3-gallate; CHEBI:4806; (-)-epigallocatechin-3-gallate ; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; SPECTRUM210239; E4143_SIAL; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; Spectrum_000316; (-)-EGCG; KBio3_001128; BSPBio_001628; Epigallocatechol, 3-gallate, (-)-; Epigallocatechin-3-gallate; E4268_SIAL; epigallocatechin gallate ; epigallocatechin-3-gallate; (-)epigallocatechin-3-gallate ; EGCG; 989E515; [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate; HMS2051K21; CS-1258; AC1L22IG; AK165605; Green tea polyphenols, Anagen; (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard; AKOS015918182; CAS-989-51-5; Epigallocatechin gallate, primary pharmaceutical reference standard; W-5069; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate; (-)-Epigallocatechin gallate, analytical standard; Q-100914; DSSTox_RID_78830; AN-15867; DSSTox_GSID_29889; (-)-Epigallocatechol gallate; FT-0604392; NCGC00164319-04; Green tea extract; MEGxp0_001166; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; N1874; CHEBI:4806; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; BG00814299; HMS3649E08; D0E9DB; Epigallocatechol, 3-gallate, (-)-; (-)-EpigallocatechinGallateHydrate; Epigallocatechin-3-gallate; AB0014381; BQM438CTEL; NC00078; ST51055716; Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material; SpecPlus_000277; Spectrum3_000244; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate; MLS000758300; (-)-Epigallocatechin gallate (EGCG); CCG-38378; Gallic acid, 3-ester with epigallocatechol, (-)-; SR-01000946601-1; NCGC00164319-01; (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate; NCGC00164319-06; DSSTox_CID_567; MCULE-3341525983; Epigallocatechin monogallate, B; Tox21_303457; SAM001247031; 4awm; K791; 989-51-5; SR-01000946601; MFCD00075940; EGCG analogs; Galloyl-L-epigallocatechol; NCGC00164319-03; (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea; Spectrum5_000102; CPD000449288; (-)-Epigallocatechin gallate; LMPK12030005; E0694; Teavigo; Epigallocatechin gallate analogs, Anagen; Epigallocatechin-3-monogallate; ACN-035233; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Sunphenon; Epigallocatechin gallate(EGCG); s2250; PF-EGCg 90; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate; 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; MLS001424000; (-)-EGCG; ZINC3870412; KBio2_000796; EGCG cpd; KBioGR_002002; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; EGCG, Anagen; NCGC00257243-01; Tox21_201468; L-Epigallocatechin gallate; cid_65064; SPBio_000035; BG01747388; Epigallocatechin gallate; KBioSS_000796; Spectrum4_001541; (-)-epigallocatechin 3-gallate; DB12116; EPIGALOCATECHIN GALLATE; ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE; KBio2_005932; I14-7747; D0U2BH; MCULE-7760530136; 2kdh; Epigallocatechin gallate, Anagen; AOB2839; SDCCGMLS-0066550.P001; 863-65-0; FR-109; ST097428; ACon1_001054; LS-2197; CCRIS 3729; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Epigallocate; GTPL7002; BDBM50070942; C22H18O11; GTPs,Anagen; SCHEMBL35258; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate; MolPort-001-741-358; DivK1c_006373; KB-206444; SR-01000759328; Teavigo;; EGCG; (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT); HY-13653; (-)-Epigallocatechin gallate, >=95%; NCGC00259019-01; Tea catechin; DS-9030; SR-01000759328-6; SR-01000759328-5; KDH; AC1Q5X0Z; KBio1_001317; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); NVP-XAA 723; KBio2_003364; EBD2138593; FT-0082796; NCGC00164319-02; C09731; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; UNII-BQM438CTEL; DTXSID1029889; WMBWREPUVVBILR-WIYYLYMNSA-N; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; (-)-Epigallocatehin gallate; Spectrum2_000168; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; (-)-Epigallocatechin gallat; SPECTRUM210239; Epigallocic acid; Epigallocatcchin Gallate; KS-0000132O; BP-30205; CHEMBL297453; SC-47284; Spectrum_000316; 3oob; (-)-Epigallocatechin gallate, >=97.0% (HPLC); KBio3_001128; BSPBio_001628; epigallo-catechin gallate | C22H18O11 | 458.4g/mol | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000573 | CDX2 | CDX-3; CDX2/AS; CDX3 | caudal type homeobox 2 |
| TCMBANKGE013634 | PLCL1 | PLCE; PLCL; PLDL1; PPP1R127; PRIP | phospholipase C like 1 (inactive) |
| TCMBANKGE005972 | NPNT | EGFL6L; POEM | nephronectin |
| TCMBANKGE006973 | DKK4 | DKK-4 | dickkopf WNT signaling pathway inhibitor 4 |
| TCMBANKGE001067 | S100A8 | 60B8AG; CAGA; CFAG; CGLA; CP-10; L1Ag; MA387; MIF; MRP8; NIF; P8 | S100 calcium binding protein A8 |
| TCMBANKGE004139 | DEGS1 | DEGS; DEGS-1; DES1; Des-1; FADS7; HLD18; MIG15; MLD | delta 4-desaturase, sphingolipid 1 |
| TCMBANKGE000973 | EGF | HOMG4; URG | epidermal growth factor |
| TCMBANKGE000562 | IL18 | IGIF; IL-18; IL-1g; IL1F4 | interleukin 18 |
| TCMBANKGE006153 | ATP4A | ATP6A | ATPase H+/K+ transporting subunit alpha |
| TCMBANKGE000144 | POU5F1P3 | OCT3; OCT4; OCT4-pg3; OTF-3; OTF3; OTF3L; Oct-3; Oct-4; POU5F1; POU5F1L; POU5FLC12 | POU class 5 homeobox 1 pseudogene 3 |
| TCMBANKGE000256 | PRKCA | AAG6; PKC-alpha; PKCA; PKCI+/-; PKCalpha; PRKACA | protein kinase C alpha |
| TCMBANKGE000626 | ATRNL1 | ALP; bA338L11.1; bA454H24.1 | attractin like 1 |
| TCMBANKGE009658 | ATP12A | ATP1AL1; H-K-ATPase; HK | ATPase H+/K+ transporting non-gastric alpha2 subunit |
| TCMBANKGE013010 | COX2 | COII; MTCO2 | cytochrome c oxidase subunit II |
| TCMBANKGE001076 | SOD2 | GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD | superoxide dismutase 2 |
| TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
| TCMBANKGE013393 | PDCD1LG2 | B7DC; Btdc; CD273; PD-L2; PDCD1L2; PDL2; bA574F11.2 | programmed cell death 1 ligand 2 |
| TCMBANKGE005209 | PHGDH | 3-PGDH; 3PGDH; HEL-S-113; NLS; NLS1; PDG; PGAD; PGD; PGDH; PHGDHD; SERA | phosphoglycerate dehydrogenase |
| TCMBANKGE000739 | NOX5 | - | NADPH oxidase 5 |
| TCMBANKGE000625 | NAT10 | ALP; Kre33; NET43 | N-acetyltransferase 10 |
| TCMBANKGE003110 | PLCE1 | NPHS3; PLCE; PPLC | phospholipase C epsilon 1 |
| TCMBANKGE007648 | SLC6A5 | GLYT-2; GLYT2; HKPX3; NET1 | solute carrier family 6 member 5 |
| TCMBANKGE012188 | FUT3 | CD174; FT3B; FucT-III; LE; Les | fucosyltransferase 3 (Lewis blood group) |
| TCMBANKGE009298 | HLA-DMA | D6S222E; DMA; HLADM; RING6 | major histocompatibility complex, class II, DM alpha |
| TCMBANKGE000945 | HES1 | HES-1; HHL; HRY; bHLHb39 | hes family bHLH transcription factor 1 |
| TCMBANKGE000620 | ATHS | ALP | atherosclerosis susceptibility (lipoprotein associated) |
| TCMBANKGE000294 | CDKN1A | CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 | cyclin dependent kinase inhibitor 1A |
| TCMBANKGE014769 | POSTN | OSF-2; OSF2; PDLPOSTN; PN | periostin |
| TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
| TCMBANKGE012756 | SLC19A1 | CHMD; FOLT; IFC-1; IFC1; REFC; RFC; RFC1; RFT-1; hRFC; hSLC19A1 | solute carrier family 19 member 1 |
| TCMBANKGE004751 | GPHN | GEPH; GPH; GPHRYN; HKPX1; MOCODC | gephyrin |
| TCMBANKGE009143 | GLRA1 | HKPX1; STHE | glycine receptor alpha 1 |
| TCMBANKGE001034 | TLR2 | CD282; TIL4 | toll like receptor 2 |
| TCMBANKGE002677 | SLC6A8 | CCDS1; CRT; CRTR; CT1; CTR5 | solute carrier family 6 member 8 |
| TCMBANKGE000331 | CALCA | CALC1; CGRP; CGRP-I; CGRP-alpha; CGRP1; CT; KC; PCT | calcitonin related polypeptide alpha |
| TCMBANKGE000825 | CDKN1B | CDKN4; KIP1; MEN1B; MEN4; P27KIP1 | cyclin dependent kinase inhibitor 1B |
| TCMBANKGE000204 | CXCL8 | GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 | C-X-C motif chemokine ligand 8 |
| TCMBANKGE000142 | CALCR | CRT; CT-R; CTR; CTR1 | calcitonin receptor |
| TCMBANKGE001126 | NFE2L2 | HEBP1; IMDDHH; NRF2; Nrf-2 | nuclear factor, erythroid 2 like 2 |
| TCMBANKGE000619 | ASRGL1 | ALP; ALP1; CRASH | asparaginase and isoaspartyl peptidase 1 |
| TCMBANKGE008033 | ADAM12 | ADAM12-OT1; CAR10; MCMP; MCMPMltna; MLTN; MLTNA | ADAM metallopeptidase domain 12 |
| TCMBANKGE000513 | CYP2C19 | CPCJ; CYP2C; CYPIIC17; CYPIIC19; P450C2C; P450IIC19 | cytochrome P450 family 2 subfamily C member 19 |
| TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
| TCMBANKGE001030 | NOTCH1 | AOS5; AOVD1; TAN1; hN1 | notch receptor 1 |
| TCMBANKGE007368 | GSTP1 | DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI | glutathione S-transferase pi 1 |
| TCMBANKGE014548 | FGF9 | FGF-9; GAF; HBFG-9; HBGF-9; SYNS3 | fibroblast growth factor 9 |
| TCMBANKGE000916 | SMO | CRJS; FZD11; Gx; SMOH | smoothened, frizzled class receptor |
| TCMBANKGE000141 | CALR | CRT; HEL-S-99n; RO; SSA; cC1qR | calreticulin |
| TCMBANKGE009888 | CCL26 | IMAC; MIP-4a; MIP-4alpha; SCYA26; TSC-1 | C-C motif chemokine ligand 26 |
| TCMBANKGE000980 | SOX2 | ANOP3; MCOPS3 | SRY-box transcription factor 2 |
| TCMBANKGE000222 | EDN1 | ARCND3; ET1; HDLCQ7; PPET1; QME | endothelin 1 |
| TCMBANKGE002615 | PLB1 | PLB; PLB/LIP | phospholipase B1 |
| TCMBANKGE009530 | GLRB | HKPX2 | glycine receptor beta |
| TCMBANKGE013318 | PLA2G1B | PLA2; PLA2A; PPLA2 | phospholipase A2 group IB |
| TCMBANKGE003758 | SLC2A10 | ATORS; ATS; GLUT10 | solute carrier family 2 member 10 |
| TCMBANKGE000823 | GABPA | E4TF1-60; E4TF1A; NFT2; NRF2; NRF2A; RCH04A07 | GA binding protein transcription factor subunit alpha |
| TCMBANKGE000956 | NR1H4 | BAR; FXR; HRR-1; HRR1; PFIC5; RIP14 | nuclear receptor subfamily 1 group H member 4 |
| TCMBANKGE006069 | SEL1L | Hrd3; PRO1063; SEL1-LIKE; SEL1L1 | SEL1L adaptor subunit of ERAD E3 ubiquitin ligase |
| TCMBANKGE006643 | YWHAZ | 14-3-3-zeta; HEL-S-3; HEL-S-93; HEL4; KCIP-1; POPCHAS; YWHAD | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
| TCMBANKGE001109 | ALPP | ALP; ALPI; IAP; PALP; PLAP; PLAP-1 | alkaline phosphatase, placental |
| TCMBANKGE000622 | SLPI | ALK1; ALP; BLPI; HUSI; HUSI-I; MPI; WAP4; WFDC4 | secretory leukocyte peptidase inhibitor |
| TCMBANKGE000795 | POU5F1 | OCT3; OCT4; OTF-3; OTF3; OTF4; Oct-3; Oct-4 | POU class 5 homeobox 1 |
| TCMBANKGE000729 | CASP1 | ICE; IL1BC; P45 | caspase 1 |
| TCMBANKGE009874 | CDKN2B | CDK4I; INK4B; MTS2; P15; TP15; p15INK4b | cyclin dependent kinase inhibitor 2B |
| TCMBANKGE000659 | TLR3 | CD283; IIAE2 | toll like receptor 3 |
| TCMBANKGE012953 | PGM3 | AGM1; IMD23; PAGM; PGM 3 | phosphoglucomutase 3 |
| TCMBANKGE000290 | NQO1 | DHQU; DIA4; DTD; NMOR1; NMORI; QR1 | NAD(P)H quinone dehydrogenase 1 |
| TCMBANKGE011953 | MEN1 | MEAI; SCG2 | menin 1 |
| TCMBANKGE000595 | ADAM9 | CORD9; MCMP; MDC9; Mltng | ADAM metallopeptidase domain 9 |
| TCMBANKGE004126 | FERMT1 | C20orf42; DTGCU2; KIND1; UNC112A; URP1 | fermitin family member 1 |
| TCMBANKGE001189 | IL1A | IL-1 alpha; IL-1A; IL1; IL1-ALPHA; IL1F1 | interleukin 1 alpha |
| TCMBANKGE006405 | CCL11 | SCYA11 | C-C motif chemokine ligand 11 |
| TCMBANKGE002029 | EPAS1 | ECYT4; HIF2A; HLF; MOP2; PASD2; bHLHe73 | endothelial PAS domain protein 1 |
| TCMBANKGE000180 | TCF4 | CDG2T; E2-2; FECD3; ITF-2; ITF2; PTHS; SEF-2; SEF2; SEF2-1; SEF2-1A; SEF2-1B; SEF2-1D; TCF-4; bHLHb19 | transcription factor 4 |
| TCMBANKGE014331 | PGA5 | Pg5 | pepsinogen A5 |
| TCMBANKGE003208 | DKK1 | DKK-1; SK | dickkopf WNT signaling pathway inhibitor 1 |
| TCMBANKGE013833 | RPS6KB2 | KLS; P70-beta; P70-beta-1; P70-beta-2; S6K-beta2; S6K2; S6KB; S6KI(2); S6Kbeta; SRK; STK14B; p70(S6K)-beta; p70S6Kb | ribosomal protein S6 kinase B2 |
| TCMBANKGE000621 | PDLIM3 | ALP | PDZ and LIM domain 3 |
| TCMBANKGE008746 | ATP7A | DSMAX; MK; MNK; SMAX3 | ATPase copper transporting alpha |
| TCMBANKGE009308 | RPL11 | DBA7; GIG34; L11; uL5 | ribosomal protein L11 |
| TCMBANKGE012046 | ARSA | ASA; MLD | arylsulfatase A |
| TCMBANKGE000623 | CCL27 | ALP; CTACK; CTAK; ESKINE; ILC; PESKY; SCYA27 | C-C motif chemokine ligand 27 |
| TCMBANKGE013109 | PSPH | PSP; PSPHD | phosphoserine phosphatase |
| TCMBANKGE000143 | POU5F1P4 | OCT3; OCT4; OTF-3; OTF3; Oct-3; Oct-4; Oct4-pg4; POU5F1; POU5FLC1 | POU class 5 homeobox 1 pseudogene 4 |
| TCMBANKGE000764 | TRPV1 | VR1 | transient receptor potential cation channel subfamily V member 1 |
| TCMBANKGE001029 | IL13 | IL-13; P600 | interleukin 13 |
| TCMBANKGE000075 | IL1RN | DIRA; ICIL-1RA; IL-1RN; IL-1ra; IL-1ra3; IL1F3; IL1RA; IRAP; MVCD4 | interleukin 1 receptor antagonist |
| TCMBANKGE008463 | CDKN2C | INK4C; p18; p18-INK4C | cyclin dependent kinase inhibitor 2C |
滇IICP备16009434号-1 |
Dai SX Lab